AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32656955 — intervention group
Group type: COMPARATOR
Intervention: Image quality scores, lesion conspicuity scores, and BI-RADS categories
Number of subjects: 224
Study 36442300 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-in-1000 appeal
Number of subjects: 0
Study 36442300 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic norms appeal
Number of subjects: 0
Study 36442300 — intervention group
Group type: COMPARATOR
Intervention: No-message control group
Number of subjects: 0
Study 33998004 — intervention group
Group type: EXPERIMENTAL
Intervention: Minoxidil with photobiomodulation
Number of subjects: 21
Study 33998004 — intervention group
Group type: COMPARATOR
Intervention: Minoxidil only
Number of subjects: 21
Study 35577469 — intervention group
Group type: EXPERIMENTAL
Intervention: T‐CRF intervention (24-week programme of three telehealth nurse‐led consultations and a personalised CRF management plan)
Number of subjects: 60
Study 35577469 — intervention group
Group type: COMPARATOR
Intervention: Usual care (specialist‐led care with a fatigue information booklet)
Number of subjects: 60
Study 33230541 — intervention group
Group type: EXPERIMENTAL
Intervention: Op Koers Online (online psychosocial group intervention)
Number of subjects: 73
Study 33230541 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 73
Study 35294908 — intervention group
Group type: EXPERIMENTAL
Intervention: Low concentration/dose groups (370-0.7, 300-1.0, and 300-0.9)
Number of subjects: 102
Study 35294908 — intervention group
Group type: EXPERIMENTAL
Intervention: Low injection rate groups (2-370 and 2-350)
Number of subjects: 102
Study 35294908 — intervention group
Group type: EXPERIMENTAL
Intervention: VMI60 keV
Number of subjects: 102
Study 35294908 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard contrast agent protocol)
Number of subjects: 102
Study 34579009 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrulline supplementation
Number of subjects: 44
Study 34579009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 32871808 — intervention group
Group type: EXPERIMENTAL
Intervention: TP‐CCRT (cisplatin plus paclitaxel)
Number of subjects: 30
Study 32871808 — intervention group
Group type: COMPARATOR
Intervention: P‐CCRT (control group)
Number of subjects: 30
Study 32871808 — intervention group
Group type: EXPERIMENTAL
Intervention: TP‐CCRT
Number of subjects: 30
Study 32871808 — intervention group
Group type: COMPARATOR
Intervention: P‐CCRT
Number of subjects: 30
Study 36447145 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate part-time patching
Number of subjects: 92
Study 36447145 — intervention group
Group type: EXPERIMENTAL
Intervention: Pencil push-up training
Number of subjects: 92
Study 36447145 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 92
Study 34535143 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein (LDL) cholesterol
Number of subjects: 361194
Study 34535143 — intervention group
Group type: EXPERIMENTAL
Intervention: Total cholesterol (TC)
Number of subjects: 361194
Study 34535143 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglycerides
Number of subjects: 361194
Study 34535143 — intervention group
Group type: EXPERIMENTAL
Intervention: High-density lipoprotein (HDL) cholesterol
Number of subjects: 361194
Study 32236395 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Training (CT) program (TEAM‐V)
Number of subjects: 40
Study 35486946 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (listening to music) for 18 sessions over six weeks
Number of subjects: 48
Study 35486946 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music therapy)
Number of subjects: 48
Study 33858011 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis oil containing 160/40 mg/ml cannabidiol/tetrahydrocannabinol (CBD/THC) for 8 weeks
Number of subjects: 56
Study 33858011 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 56
Study 33642460 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge about vitamin A fortified edible oils
Number of subjects: 400
Study 33642460 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge about vitamin A fortified rice
Number of subjects: 400
Study 33642460 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of vitamin A fortified edible oils
Number of subjects: 400
Study 33642460 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of vitamin A fortified rice
Number of subjects: 400
Study 33642460 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge and consumption rates
Number of subjects: 400
Study 32331983 — intervention group
Group type: EXPERIMENTAL
Intervention: D2 lymph node dissection (LND)
Number of subjects: 1121
Study 32331983 — intervention group
Group type: COMPARATOR
Intervention: D1+ lymph node dissection (LND)
Number of subjects: 1121
Study 34241691 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3442
Study 34241691 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-TNF biologics
Number of subjects: 3442
Study 34241691 — intervention group
Group type: EXPERIMENTAL
Intervention: JAK inhibitors
Number of subjects: 3442
Study 33621423 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA
Number of subjects: 25
Study 33621423 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 25
Study 33621423 — intervention group
Group type: COMPARATOR
Intervention: Comparison between L-NMMA and Saline
Number of subjects: 25
Study 33142537 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/kg Mn
Number of subjects: 120
Study 33142537 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/kg Mn
Number of subjects: 120
Study 33142537 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 × 10^9 CFU/kg BS
Number of subjects: 120
Study 33142537 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 and 30 mg/kg Mn and 5 × 10^9 CFU/kg BS
Number of subjects: 120
Study 33142537 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 and 30 mg/kg Mn
Number of subjects: 120
Study 33142537 — intervention group
Group type: EXPERIMENTAL
Intervention: Mn and BS
Number of subjects: 120
Study 35060855 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fidelity simulation
Number of subjects: 0
Study 35060855 — intervention group
Group type: COMPARATOR
Intervention: High-fidelity simulation (control)
Number of subjects: 0
Study 34229655 — intervention group
Group type: EXPERIMENTAL
Intervention: Duo positive airway pressure (NDUOPAP)
Number of subjects: 148
Study 34229655 — intervention group
Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (NCPAP)
Number of subjects: 148
Study 34655765 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated mobile phone text messages for 90 days
Number of subjects: 121
Study 34655765 — intervention group
Group type: COMPARATOR
Intervention: Standard perioperative communication
Number of subjects: 121
Study 33050752 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy
Number of subjects: 88
Study 33050752 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 88
Study 36544645 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg remimazolam tosylate
Number of subjects: 120
Study 36544645 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg remimazolam tosylate
Number of subjects: 120
Study 36544645 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg remimazolam tosylate
Number of subjects: 120
Study 36544645 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study 33363715 — intervention group
Group type: EXPERIMENTAL
Intervention: anodal transcranial direct current stimulation (atDCS)
Number of subjects: 16
Study 33363715 — intervention group
Group type: COMPARATOR
Intervention: sham stimulation
Number of subjects: 16
Study 35095080 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild WMH (0.26% ± 0.14% of ICV)
Number of subjects: 78
Study 35095080 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate WMH (0.70% ± 0.15% of ICV)
Number of subjects: 78
Study 35095080 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe WMH (1.75% ± 0.67% of ICV)
Number of subjects: 78
Study 34090464 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (100 mg/kg IV, 3 doses: 2 intraoperative and 1 postoperative)
Number of subjects: 60
Study 34090464 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 60
Study 35025723 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham tDCS with caffeine intake (Sham+Caff)
Number of subjects: 16
Study 35025723 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS with caffeine intake (a-tDCS+Caff)
Number of subjects: 16
Study 35025723 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS with placebo intake (a-tDCS+Pla)
Number of subjects: 16
Study 35025723 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS with placebo intake (Sham+Pla)
Number of subjects: 16
Study 34426097 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health worker-led decision-coaching program
Number of subjects: 0
Study 34426097 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32970478 — intervention group
Group type: EXPERIMENTAL
Intervention: SBRT by linear accelerator (Linac)
Number of subjects: 106
Study 32970478 — intervention group
Group type: COMPARATOR
Intervention: Cyberknife®
Number of subjects: 106
Study 32970478 — intervention group
Group type: EXPERIMENTAL
Intervention: SBRT by linear accelerator (Linac) and Cyberknife®
Number of subjects: 106
Study 33630716 — intervention group
Group type: EXPERIMENTAL
Intervention: Challenging Horizons Program - After-School version (CHP-AS)
Number of subjects: 326
Study 33630716 — intervention group
Group type: EXPERIMENTAL
Intervention: Challenging Horizons Program - Mentoring version (CHP-M)
Number of subjects: 326
Study 33630716 — intervention group
Group type: COMPARATOR
Intervention: Routine community care
Number of subjects: 326
Study 33956387 — intervention group
Group type: EXPERIMENTAL
Intervention: MET + IIT
Number of subjects: 108
Study 33956387 — intervention group
Group type: COMPARATOR
Intervention: MET
Number of subjects: 108
Study 36038376 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed reality mentoring
Number of subjects: 14
Study 36038376 — intervention group
Group type: COMPARATOR
Intervention: Audio-only mentoring
Number of subjects: 14
Study 34684600 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Nutritional Intervention through Social Networks 2.0
Number of subjects: 77
Study 34684600 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 77
Study 35201518 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflawell® syrup (Boswellia extract formulation enriched for boswellic acids)
Number of subjects: 47
Study 35201518 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 33904391 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular advancement device (MAD) during sleep
Number of subjects: 18
Study 33904391 — intervention group
Group type: COMPARATOR
Intervention: Oral appliance (sham MAD)
Number of subjects: 18
Study 33904391 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 18
Study 33904391 — intervention group
Group type: COMPARATOR
Intervention: First dorsal interosseous muscle (control)
Number of subjects: 18
Study 36041962 — intervention group
Group type: EXPERIMENTAL
Intervention: Myomectomy
Number of subjects: 311
Study 36041962 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 311
Study 35124400 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA (75 mg)
Number of subjects: 60
Study 33164319 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive ATP
Number of subjects: 146
Study 33164319 — intervention group
Group type: COMPARATOR
Intervention: DDD RP (from MINERVA trial)
Number of subjects: 146
Study 33164319 — intervention group
Group type: COMPARATOR
Intervention: Control DDDR (from MINERVA trial)
Number of subjects: 146
Study 33164319 — intervention group
Group type: COMPARATOR
Intervention: MVP (from MINERVA trial)
Number of subjects: 146
Study 34856171 — intervention group
Group type: EXPERIMENTAL
Intervention: MLC901 (NeuroAiD II)
Number of subjects: 125
Study 33203405 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening and patient-tailored care for cognitive and emotional problems, including a short, individualized, semi-structured consultation by specialized nurses, screening for cognitive and emotional problems, screening for restrictions in participation, promotion of self-management strategies, and a decision tool for referral to rehabilitation services, performed approximately 6 weeks after the stroke for about 60 minutes.
Number of subjects: 0
Study 33203405 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group).
Number of subjects: 0
Study 34896443 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine in submucosal injectate
Number of subjects: 0
Study 34896443 — intervention group
Group type: COMPARATOR
Intervention: Injectate alone (Control)
Number of subjects: 0
Study 33248438 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) at 30% of maximal inspiratory pressure
Number of subjects: 30
Study 33248438 — intervention group
Group type: COMPARATOR
Intervention: Placebo Inspiratory Muscle Training (P‐IMT) at 2% of maximal inspiratory pressure
Number of subjects: 30
Study 36033577 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-port thoracoscopic surgery
Number of subjects: 68
Study 36033577 — intervention group
Group type: COMPARATOR
Intervention: Three-port thoracoscopic surgery
Number of subjects: 68
Study 32073145 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ossiculoplasty with PORP
Number of subjects: 118
Study 32073145 — intervention group
Group type: COMPARATOR
Intervention: Microscopic ossiculoplasty with PORP
Number of subjects: 118
Study 32073145 — intervention group
Group type: EXPERIMENTAL
Intervention: TORP ossiculoplasty
Number of subjects: 118
Study 32073145 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic ossiculoplasty and Microscopic ossiculoplasty
Number of subjects: 118
Study 35148378 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefiderocol
Number of subjects: 24
Study 35148378 — intervention group
Group type: COMPARATOR
Intervention: Best-available therapy
Number of subjects: 24
Study 35148378 — intervention group
Group type: COMPARATOR
Intervention: High-dose meropenem
Number of subjects: 24
Study 34366152 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan (100 mg and 200 mg)
Number of subjects: 132
Study 34366152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 34366152 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan
Number of subjects: 132
Study 32291607 — intervention group
Group type: EXPERIMENTAL
Intervention: Thick-needle therapy (TNT)
Number of subjects: 146
Study 32291607 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture therapy (AT)
Number of subjects: 146
Study 34959111 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz repetitive transcranial magnetic stimulation (rTMS) treatment twice a week
Number of subjects: 32
Study 34959111 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control group)
Number of subjects: 32
Study 34959111 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 32
Study 33377957 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 24
Study 33377957 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine
Number of subjects: 24
Study 33377957 — intervention group
Group type: EXPERIMENTAL
Intervention: Both (Ephedrine and Phenylephrine)
Number of subjects: 24
Study 36367835 — intervention group
Group type: EXPERIMENTAL
Intervention: SHIFT intervention (6-month duration)
Number of subjects: 25
Study 33228794 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned early delivery (initiation of delivery within 48 h of randomisation)
Number of subjects: 0
Study 33228794 — intervention group
Group type: COMPARATOR
Intervention: Routine care (expectant management)
Number of subjects: 0
Study 37575887 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-only warning labels
Number of subjects: 3051
Study 37575887 — intervention group
Group type: EXPERIMENTAL
Intervention: Icon warning labels
Number of subjects: 3051
Study 37575887 — intervention group
Group type: EXPERIMENTAL
Intervention: Warnings about addiction
Number of subjects: 3051
Study 37575887 — intervention group
Group type: COMPARATOR
Intervention: Control labels
Number of subjects: 3051
Study 33773084 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated control of FiO2 using PRICO® system
Number of subjects: 20
Study 33773084 — intervention group
Group type: COMPARATOR
Intervention: Manual control of FiO2
Number of subjects: 20
Study 35129064 — intervention group
Group type: EXPERIMENTAL
Intervention: Home Exercise Assessment Tool (HEAT)
Number of subjects: 30
Study 33611615 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (100,000 IU) every 3 months for 18 months
Number of subjects: 3046
Study 33611615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3046
Study 34342608 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional visualization system (3D group)
Number of subjects: 201
Study 34342608 — intervention group
Group type: COMPARATOR
Intervention: Traditional microscope (TM group)
Number of subjects: 201
Study 32108262 — intervention group
Group type: EXPERIMENTAL
Intervention: Juçara group (5 g lyophilized juçara)
Number of subjects: 35
Study 32108262 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (5 g of maltodextrin)
Number of subjects: 35
Study 36135712 — intervention group
Group type: EXPERIMENTAL
Intervention: Trilaciclib prior to gemcitabine plus carboplatin (GCb)
Number of subjects: 0
Study 36135712 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine plus carboplatin (GCb) alone
Number of subjects: 0
Study 33031748 — intervention group
Group type: EXPERIMENTAL
Intervention: Genome-wide association analysis of circulating metabolites
Number of subjects: 3926
Study 33031748 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization (MR) analysis
Number of subjects: 3926
Study 35797640 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium clip-dental floss traction
Number of subjects: 68
Study 35797640 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard ERCP without traction)
Number of subjects: 68
Study 33837473 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized scripts offering an interpreter (three unique scripted questions)
Number of subjects: 55
Study 33837473 — intervention group
Group type: EXPERIMENTAL
Intervention: Scripted question: 'In what language do you prefer to receive your medical care?'
Number of subjects: 55
Study 36227931 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based physical exercise intervention supported by a mobile application
Number of subjects: 712
Study 36227931 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 712
Study 33846866 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene (18 mg)
Number of subjects: 18
Study 33846866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 32372078 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial injury (scratching)
Number of subjects: 200
Study 32372078 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study 35187877 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 49
Study 35187877 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 49
Study 35187877 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 49
Study 34795208 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide
Number of subjects: 100
Study 34795208 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 35658650 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Ankle Pump Exercise (3 times/min)
Number of subjects: 307
Study 35658650 — intervention group
Group type: EXPERIMENTAL
Intervention: Selected Ankle Pump Exercise (30 times/min)
Number of subjects: 307
Study 35658650 — intervention group
Group type: COMPARATOR
Intervention: Control (rest)
Number of subjects: 307
Study 33151787 — intervention group
Group type: EXPERIMENTAL
Intervention: PET/CT scans at premaintenance (PM)
Number of subjects: 228
Study 33151787 — intervention group
Group type: EXPERIMENTAL
Intervention: FS and BMS < 4
Number of subjects: 228
Study 35599921 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaine (2.5 g·d‐1)
Number of subjects: 10
Study 37422602 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dose albumin (1.5 g/kg at diagnosis and 1 g/kg on day three, infused over six hours)
Number of subjects: 63
Study 37422602 — intervention group
Group type: COMPARATOR
Intervention: Reduced dose albumin (0.75 g/kg at diagnosis and 0.5 g/kg 48 hours later, infused over six hours)
Number of subjects: 63
Study 37422602 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dose albumin
Number of subjects: 63
Study 37422602 — intervention group
Group type: COMPARATOR
Intervention: Reduced dose albumin
Number of subjects: 63
Study 33058735 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) intervention in addition to conventional cognitive rehabilitation (CR)
Number of subjects: 61
Study 33058735 — intervention group
Group type: COMPARATOR
Intervention: Conventional cognitive rehabilitation (CR)
Number of subjects: 61
Study 32358661 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic Acid (HA) injection
Number of subjects: 54
Study 32358661 — intervention group
Group type: EXPERIMENTAL
Intervention: Peptide (Prostrolane®) injection
Number of subjects: 54
Study 32358661 — intervention group
Group type: COMPARATOR
Intervention: Platelet-Rich Plasma (PRP) injection
Number of subjects: 54
Study 34535524 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice Facilitation (PF) for 1 year
Number of subjects: 32
Study 32506481 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized pneumoperitoneum pressure (IPP) strategy
Number of subjects: 166
Study 32506481 — intervention group
Group type: COMPARATOR
Intervention: Standard pneumoperitoneum pressure (SPP) strategy
Number of subjects: 166